NCT04224337 2025-12-31Phase II Study of Durvalumab ,Doxorubicin, and Ifosfamide in Pulmonary Sarcomatoid CarcinomaSeoul National University HospitalPhase 2 Completed16 enrolled
NCT02324296 2025-06-11PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive CasesAzienda USL Reggio Emilia - IRCCSCompleted46 enrolled